Healthcare Realty Trust Incorporated (NYSE:HR) Shares Sold by Lecap Asset Management Ltd.

Lecap Asset Management Ltd. cut its holdings in shares of Healthcare Realty Trust Incorporated (NYSE:HRFree Report) by 49.6% during the fourth quarter, HoldingsChannel.com reports. The firm owned 44,956 shares of the real estate investment trust’s stock after selling 44,285 shares during the period. Lecap Asset Management Ltd.’s holdings in Healthcare Realty Trust were worth $762,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently made changes to their positions in HR. Pzena Investment Management LLC acquired a new position in shares of Healthcare Realty Trust in the 3rd quarter valued at $40,392,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its holdings in shares of Healthcare Realty Trust by 358.2% in the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 2,142,110 shares of the real estate investment trust’s stock valued at $38,879,000 after purchasing an additional 1,674,583 shares during the period. Sumitomo Mitsui Trust Group Inc. raised its stake in shares of Healthcare Realty Trust by 289.5% in the fourth quarter. Sumitomo Mitsui Trust Group Inc. now owns 1,552,109 shares of the real estate investment trust’s stock worth $26,308,000 after purchasing an additional 1,153,657 shares during the last quarter. Barclays PLC lifted its holdings in shares of Healthcare Realty Trust by 116.2% during the third quarter. Barclays PLC now owns 722,582 shares of the real estate investment trust’s stock worth $13,117,000 after purchasing an additional 388,305 shares during the period. Finally, Capital Investment Advisors LLC boosted its position in Healthcare Realty Trust by 31.0% in the fourth quarter. Capital Investment Advisors LLC now owns 469,323 shares of the real estate investment trust’s stock valued at $7,955,000 after buying an additional 111,125 shares during the last quarter.

Insiders Place Their Bets

In other news, Director Thomas N. Bohjalian purchased 7,750 shares of the business’s stock in a transaction on Friday, November 22nd. The shares were bought at an average price of $17.39 per share, with a total value of $134,772.50. Following the completion of the transaction, the director now directly owns 50,002 shares in the company, valued at approximately $869,534.78. This represents a 18.34 % increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Peter F. Sr Lyle, Sr. acquired 10,000 shares of the firm’s stock in a transaction dated Friday, December 13th. The stock was purchased at an average cost of $17.21 per share, with a total value of $172,100.00. Following the completion of the acquisition, the director now directly owns 26,576 shares of the company’s stock, valued at approximately $457,372.96. This trade represents a 60.33 % increase in their position. The disclosure for this purchase can be found here. Over the last quarter, insiders have purchased 18,750 shares of company stock valued at $323,723. 0.56% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

Several research analysts recently weighed in on HR shares. Wedbush cut Healthcare Realty Trust from a “neutral” rating to an “underperform” rating and reduced their price target for the company from $18.00 to $16.00 in a research report on Thursday, January 2nd. Jefferies Financial Group cut shares of Healthcare Realty Trust from a “buy” rating to a “hold” rating and decreased their target price for the company from $19.00 to $17.00 in a research note on Thursday, January 2nd. Finally, JPMorgan Chase & Co. downgraded shares of Healthcare Realty Trust from an “overweight” rating to a “neutral” rating and set a $19.00 price target on the stock. in a report on Friday, December 20th. Two equities research analysts have rated the stock with a sell rating and four have assigned a hold rating to the company’s stock. According to MarketBeat.com, Healthcare Realty Trust currently has an average rating of “Hold” and an average target price of $17.00.

View Our Latest Stock Report on Healthcare Realty Trust

Healthcare Realty Trust Stock Down 0.0 %

HR stock opened at $16.55 on Friday. The business has a 50 day moving average price of $16.93 and a 200 day moving average price of $17.49. The stock has a market cap of $5.86 billion, a price-to-earnings ratio of -10.47 and a beta of 0.94. Healthcare Realty Trust Incorporated has a fifty-two week low of $12.77 and a fifty-two week high of $18.90.

Healthcare Realty Trust Profile

(Free Report)

Healthcare Realty Trust, Inc provides real estate investment services. It owns, leases, manages, acquires, finances, develops, and redevelops income-producing real estate properties associated primarily with the delivery of outpatient healthcare services throughout the United States of America. The company was founded by David R.

Further Reading

Want to see what other hedge funds are holding HR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Healthcare Realty Trust Incorporated (NYSE:HRFree Report).

Institutional Ownership by Quarter for Healthcare Realty Trust (NYSE:HR)

Receive News & Ratings for Healthcare Realty Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthcare Realty Trust and related companies with MarketBeat.com's FREE daily email newsletter.